Average Co-Inventor Count = 7.45
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Methylgene, Inc. (14 from 53 patents)
2. Neomed Institute (4 from 10 patents)
3. Epigenetix, Inc. (2 from 2 patents)
20 patents:
1. 11981657 - Substituted benzimidazoles, their preparation and their use as pharmaceuticals
2. 11365186 - Substituted benzimidazoles, their preparation and their use as pharmaceuticals
3. 10836742 - N-substituted bicyclic lactams, their preparation and their use as pharmaceuticals
4. 10703740 - Substituted benzimidazoles, their preparation and their use as pharmaceuticals
5. 10519151 - Substituted [1,2,4]triazolo[4,3-A]pyridines, their preparation and their use as pharmaceuticals
6. 10501459 - Substituted imidazo[1,2-a]pyridines as bromodomain inhibitors
7. 9018378 - Processes and intermediates for preparing fused heterocyclic kinase inhibitors
8. 8906852 - Inhibitors of protein tyrosine kinase activity
9. 8907091 - Processes and intermediates for preparing fused heterocyclic kinase inhibitors
10. 8846927 - Inhibitors of protein tyrosine kinase activity
11. 8759522 - Inhibitors of protein tyrosine kinase activity
12. 8729268 - Inhibitors of protein tyrosine kinase activity
13. 8470850 - Inhibitors of VEGF receptor and HGF receptor signalling
14. 8455484 - Selected inhibitors of protein tyrosine kinase activity
15. 8404846 - Inhibitors of protein tyrosine kinase activity